An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers

Launched by ROSWELL PARK CANCER INSTITUTE · May 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new support tool designed to help patients with advanced bladder cancer and their caregivers work together more effectively in managing their care. The tool provides education and guidance to improve how patients make treatment decisions and plan their care. It aims to support those dealing with bladder cancer that is locally advanced (spread to nearby areas), metastatic (spread to distant organs), or unresectable (cannot be surgically removed).

To participate in this study, patients need to be at least 18 years old, have a diagnosis of advanced bladder cancer, and be receiving or planning to receive treatment at Roswell Park Comprehensive Cancer Center. Caregivers of these patients can also join the study if they meet similar age and language requirements. Throughout the trial, participants can expect to receive helpful information and support to enhance their involvement in the treatment process. This trial is currently recruiting participants, and it focuses on making sure that patients and their caregivers have the tools they need to navigate their cancer journey effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • PATIENTS: Age ≥ 18 years
• • PATIENTS: Metastatic or locally advanced, unresectable bladder cancer
• • PATIENTS: Receiving or planning to receive systemic therapy for bladder cancer at Roswell Park Comprehensive Cancer Center (RPCCC)
• • PATIENTS: Subjects can be enrolled any time from initial diagnosis of advanced disease to within 8 weeks after initiation of first-line systemic therapy for advanced bladder cancer
• • PATIENTS: Able to speak, understand, read, and write English
• • CAREGIVERS: Age ≥ 18 years
• • CAREGIVERS: Only caregivers of enrolled patients will be included in the study
• • CAREGIVERS: Should be able to speak, understand, read, and write English
• • CAREGIVERS: Caregivers will be enrolled in the genitourinary (GU) clinic during the same time window as for patient enrollment (from initial visit to within 8 weeks of patients starting frontline therapy)
• Exclusion Criteria:
• • PATIENTS: Not receiving any form of systemic therapy for bladder cancer due to Eastern Cooperative Oncology Group (ECOG) performance status (PS) \> 3, co-morbidities, or inadequate organ function
• • PATIENTS: Predominantly small cell histology
• • PATIENTS: Adults with impaired decision-making capacity, assessed by the study team to be unable to participate in ENST-based education and surveys
• • PATIENTS: Pregnant women
• • CAREGIVERS: Cognitively impaired adults/adults with impaired decision-making capacity
• • CAREGIVERS: Individuals who are not yet adults (infants, children, teenagers)